| The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients V Matson, J Fessler, R Bao, T Chongsuwat, Y Zha, ML Alegre, JJ Luke, ... Science 359 (6371), 104-108, 2018 | 2779 | 2018 |
| Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity S Spranger, R Bao, TF Gajewski Nature 523 (7559), 231-235, 2015 | 2758 | 2015 |
| The genome of the model beetle and pest Tribolium castaneum. S Richards, RA Gibbs, GM Weinstock, SJ Brown, R Denell, RW Beeman, ... Nature 452 (7190), 949-955, 2008 | 1474 | 2008 |
| WNT/β-catenin pathway activation correlates with immune exclusion across human cancers JJ Luke, R Bao, RF Sweis, S Spranger, TF Gajewski Clinical Cancer Research 25 (10), 3074-3083, 2019 | 589 | 2019 |
| Healthy infants harbor intestinal bacteria that protect against food allergy T Feehley, CH Plunkett, R Bao, SM Choi Hong, E Culleen, P Belda-Ferre, ... Nature medicine 25 (3), 448-453, 2019 | 434 | 2019 |
| Density of immunogenic antigens does not explain the presence or absence of the T-cell–inflamed tumor microenvironment in melanoma S Spranger, JJ Luke, R Bao, Y Zha, KM Hernandez, Y Li, AP Gajewski, ... Proceedings of the National Academy of Sciences 113 (48), E7759-E7768, 2016 | 403 | 2016 |
| T cell–inflamed versus non-T cell–inflamed tumors: a conceptual framework for cancer immunotherapy drug development and combination therapy selection JA Trujillo, RF Sweis, R Bao, JJ Luke Cancer immunology research 6 (9), 990-1000, 2018 | 383 | 2018 |
| Reimagining IDO pathway inhibition in cancer immunotherapy via downstream focus on the tryptophan–kynurenine–aryl hydrocarbon axis BW Labadie, R Bao, JJ Luke Clinical Cancer Research 25 (5), 1462-1471, 2019 | 360 | 2019 |
| Molecular drivers of the non–T-cell-inflamed tumor microenvironment in urothelial bladder cancer RF Sweis, S Spranger, R Bao, GP Paner, WM Stadler, G Steinberg, ... Cancer immunology research 4 (7), 563-568, 2016 | 349 | 2016 |
| Review of current methods, applications, and data management for the bioinformatics analysis of whole exome sequencing R Bao, L Huang, J Andrade, W Tan, WA Kibbe, H Jiang, G Feng Cancer informatics 13, CIN. S13779, 2014 | 296 | 2014 |
| A massive expansion of effector genes underlies gall-formation in the wheat pest Mayetiola destructor C Zhao, LN Escalante, H Chen, TR Benatti, J Qu, S Chellapilla, ... Current Biology 25 (5), 613-620, 2015 | 196 | 2015 |
| Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing CHL Kürten, A Kulkarni, AR Cillo, PM Santos, AK Roble, S Onkar, ... Nature communications 12 (1), 7338, 2021 | 173 | 2021 |
| Pembrolizumab plus ipilimumab following anti-PD-1/L1 failure in melanoma DJ Olson, Z Eroglu, B Brockstein, AS Poklepovic, M Bajaj, S Babu, ... Journal of Clinical Oncology 39 (24), 2647-2655, 2021 | 165 | 2021 |
| Analysis and correction of crosstalk effects in pathway analysis M Donato, Z Xu, A Tomoiaga, JG Granneman, RG MacKenzie, R Bao, ... Genome research 23 (11), 1885-1893, 2013 | 164 | 2013 |
| PD-L1 gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T-cell–inflamed phenotype J Godfrey, S Tumuluru, R Bao, M Leukam, G Venkataraman, J Phillip, ... Blood, The Journal of the American Society of Hematology 133 (21), 2279-2290, 2019 | 121 | 2019 |
| Overcoming PD-1 blockade resistance with CpG-A toll-like receptor 9 agonist vidutolimod in patients with metastatic melanoma A Ribas, T Medina, JM Kirkwood, Y Zakharia, R Gonzalez, D Davar, ... Cancer discovery 11 (12), 2998-3007, 2021 | 119 | 2021 |
| Genomic and gene regulatory signatures of cryptozoic adaptation: Loss of blue sensitive photoreceptors through expansion of long wavelength-opsin expression in the red flour … M Jackowska, R Bao, Z Liu, EC McDonald, TA Cook, M Friedrich Frontiers in zoology 4, 1-11, 2007 | 113 | 2007 |
| Fecal microbiome and metabolome differ in healthy and food-allergic twins R Bao, LA Hesser, Z He, X Zhou, KC Nadeau, CR Nagler The Journal of clinical investigation 131 (2), 2021 | 111 | 2021 |
| Development and validation of a combined hypoxia and immune prognostic classifier for head and neck cancer JM Brooks, AN Menezes, M Ibrahim, L Archer, N Lal, CJ Bagnall, ... Clinical Cancer Research 25 (17), 5315-5328, 2019 | 94 | 2019 |
| Tumor cell IDO enhances immune suppression and decreases survival independent of tryptophan metabolism in glioblastoma L Zhai, A Bell, E Ladomersky, KL Lauing, L Bollu, B Nguyen, M Genet, ... Clinical cancer research 27 (23), 6514-6528, 2021 | 83 | 2021 |
Jorge Andrade, Ph.D.Executive Director and Global Head of Bioinformatics and Genomics at Kite Pharma, a Gilead companyVahvistettu sähköpostiosoite verkkotunnuksessa kitepharma.com
